Virtual Library
Start Your Search
B. Besse
Moderator of
-
+
The role of antiangiogenic agents in NSCLC: Are we making progress? (ID 43)
- Event: ELCC 2017
- Type: Young Oncologist session
- Track:
- Presentations: 2
-
+
Biomarker approaches for optimisation of antiangiogenic therapy (ID 138)
08:00 - 08:50 | Author(s): M. Reck
- Abstract
- Presentation
Abstract not provided
Only Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login, select "Add to Cart" and proceed to checkout. If you would like to become a member of IASLC, please click here.
-
+
State of the art in first and subsequent lines of the NSCLC treatment (ID 134)
08:00 - 08:50 | Author(s): B. Besse
- Abstract
Abstract not provided
Author of
-
+
Industry Satellite Symposium 3 (ID 54)
- Event: ELCC 2017
- Type: Industry Satellite Symposium
- Track:
- Presentations: 1
-
+
Is there a role for second-line immunotherapy in patients with PD-L1 negative NSCLC? (ID 22)
- Event: ELCC 2017
- Type: Controversy session
- Track:
- Presentations: 1
- Moderators:M. Reck, L. Paz-Ares
- Coordinates: 5/07/2017, 09:15 - 10:15, Room A
-
+
No (ID 91)
09:15 - 10:15 | Author(s): B. Besse
- Abstract
Abstract not provided
-
+
The role of antiangiogenic agents in NSCLC: Are we making progress? (ID 43)
- Event: ELCC 2017
- Type: Young Oncologist session
- Track:
- Presentations: 1
